chr19-2733010-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_144564.5(SLC39A3):c.686C>T(p.Ala229Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000375 in 1,599,014 control chromosomes in the GnomAD database, with no homozygous occurrence. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_144564.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A3 | NM_144564.5 | c.686C>T | p.Ala229Val | missense_variant | 3/3 | ENST00000269740.9 | NP_653165.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A3 | ENST00000269740.9 | c.686C>T | p.Ala229Val | missense_variant | 3/3 | 1 | NM_144564.5 | ENSP00000269740.3 | ||
ENSG00000267001 | ENST00000586572.1 | c.210+4038C>T | intron_variant | 4 | ENSP00000467958.1 | |||||
SLC39A3 | ENST00000545664.5 | c.686C>T | p.Ala229Val | missense_variant | 3/4 | 2 | ENSP00000445345.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000346 AC: 5AN: 1446968Hom.: 0 Cov.: 37 AF XY: 0.00000418 AC XY: 3AN XY: 718500
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152046Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2024 | The c.686C>T (p.A229V) alteration is located in exon 3 (coding exon 2) of the SLC39A3 gene. This alteration results from a C to T substitution at nucleotide position 686, causing the alanine (A) at amino acid position 229 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at